Innovation Act
A BILL
To amend title 35, United States Code, and the Leahy-Smith America Invents Act to make improvements and technical corrections, and for other purposes.
Sec. 2 Definitions
Sec. 3 Patent infringement actions
“281A. Pleading requirements for patent infringement actions
“(a) Pleading requirements—Except as provided in subsection (b), in a civil action in which a party asserts a claim for relief arising under any Act of Congress relating to patents, a party alleging infringement shall include in the initial complaint, counterclaim, or cross-claim for patent infringement, unless the information is not reasonably accessible to such party, the following:
“(1) An identification of each patent allegedly infringed.
“(2) An identification of all claims necessary to produce the identification (under paragraph (3)) of each process, machine, manufacture, or composition of matter (referred to in this section as an ‘accused instrumentality’) that is alleged to infringe any claim of each patent that is identified under paragraph (1).
“(3) For each claim identified under paragraph (2), an identification of each accused instrumentality alleged to infringe the claim.
“(4) For each accused instrumentality identified under paragraph (3), an identification with particularity, if known, of—
“(A) the name or model number (or a representative model number) of each accused instrumentality; or
“(B) if there is no name or model number, a description of each accused instrumentality.
“(5) For each accused instrumentality identified under paragraph (3), a clear and concise statement of—
“(A) where each element of each claim identified under paragraph (2) is found within the accused instrumentality; and
“(B) with detailed specificity, how each limitation of each claim identified under paragraph (2) is met by the accused instrumentality.
“(6) For each claim of indirect infringement, a description of the acts of the alleged indirect infringer that contribute to or are inducing the direct infringement.
“(7) A description of the authority of the party alleging infringement to assert each patent identified under paragraph (1) and of the grounds for the court’s jurisdiction.
“(b) Information not readily accessible—If information required to be disclosed under subsection (a) is not readily accessible to a party after an inquiry reasonable under the circumstances, as required by Rule 11 of the Federal Rules of Civil Procedure, that information may instead be generally described, along with an explanation of why such undisclosed information was not readily accessible, and of any efforts made by such party to access such information.
“(c) Amendment of pleadings—Nothing in this section shall be construed to affect a party’s ability to amend pleadings as specified in the Federal Rules of Civil Procedure. Amendments permitted by the court are subject to the pleading requirements set forth in this section.
“(d) Confidential information—A party required to disclose information described under subsection (a) may file, under seal, information believed to be confidential, with a motion setting forth good cause for such sealing. If such motion is denied by the court, the party may seek to file an amended complaint.
“(e) Exemption—A civil action that includes a claim for relief arising under section 271(e)(2) shall not be subject to the requirements of subsection (a).”
“285. Fees and other expenses
“(a) Award—The court shall award, to a prevailing party, reasonable fees and other expenses incurred by that party in connection with a civil action in which any party asserts a claim for relief arising under any Act of Congress relating to patents, unless the court finds that the position and conduct of the nonprevailing party or parties were reasonably justified in law and fact or that special circumstances (such as severe economic hardship to a named inventor) make an award unjust.
“(b) Certification and recovery—Upon motion of any party to the action, the court shall require another party to the action to certify whether or not the other party will be able to pay an award of fees and other expenses if such an award is made under subsection (a). If a nonprevailing party is unable to pay an award that is made against it under subsection (a), the court may make a party that has been joined under section 299(d) with respect to such party liable for the unsatisfied portion of the award.
“(c) Covenant not to sue—A party to a civil action who asserts a claim for relief arising under any Act of Congress relating to patents against another party, and who subsequently unilaterally (i) seeks dismissal of the action without consent of the other party and (ii) extends to such other party a covenant not to sue for infringement with respect to the patent or patents at issue, may be the subject of a motion for attorneys fees under subsection (a) as if it were a non-prevailing party, unless the party asserting such claim would have been entitled, at the time that such covenant was extended, to dismiss voluntarily the action without a court order under Rule 41 of the Federal Rules of Civil Procedure, or the interests of justice require otherwise.”
“(d) Joinder of interested parties
“(1) Joinder—Except as otherwise provided under this subsection, in a civil action arising under any Act of Congress relating to patents in which fees and other expenses have been awarded under section 285 to a prevailing party defending against an allegation of infringement of a patent claim, and in which the nonprevailing party alleging infringement is unable to pay the award of fees and other expenses, the court shall grant a motion by the prevailing party to join an interested party if such prevailing party shows that the nonprevailing party has no substantial interest in the subject matter at issue other than asserting such patent claim in litigation.
“(2) Limitation on joinder
“(A) Discretionary denial of motion—The court may deny a motion to join an interested party under paragraph (1) if—
“(i) the interested party is not subject to service of process; or
“(ii) joinder under paragraph (1) would deprive the court of subject matter jurisdiction or make venue improper.
“(B) Required denial of motion—The court shall deny a motion to join an interested party under paragraph (1) if—
“(i) the interested party did not timely receive the notice required by paragraph (3); or
“(ii) within 30 days after receiving the notice required by paragraph (3), the interested party renounces, in writing and with notice to the court and the parties to the action, any ownership, right, or direct financial interest (as described in paragraph (4)) that the interested party has in the patent or patents at issue.
“(3) Notice requirement—An interested party may not be joined under paragraph (1) unless it has been provided actual notice, within 30 days after the expiration of the time period during which a certification under paragraph (4)(B) is required to be filed, that the interested party has been identified in the initial disclosure under section 290(b) and that such party may therefore be an interested party subject to joinder under this subsection. Such notice shall be provided by the party who subsequently moves to join the interested party under paragraph (1), and shall include language that—
“(A) identifies the action, the parties thereto, the patent or patents at issue, and the pleading or other paper that identified the party under section 290(b); and
“(B) informs the party that it may be joined in the action and made subject to paying an award of fees and other expenses under section 285(b) if—
“(i) fees and other expenses are awarded in the action against the party alleging infringement of the patent or patents at issue under section 285(a);
“(ii) the party alleging infringement is unable to pay the award of fees and other expenses;
“(iii) the party receiving notice under this paragraph is determined by the court to be an interested party; and
“(iv) the party receiving notice under this paragraph has not, within 30 days after receiving such notice, renounced in writing, and with notice to the court and the parties to the action, any ownership, right, or direct financial interest (as described in paragraph (4)) that the interested party has in the patent or patents at issue.
“(4) Additional requirements for joinder
“(A) Initial statement—This subsection shall not apply to an action unless a party defending against an allegation of infringement of a patent claim files, not later than 14 days before the date on which a scheduling conference is held or the date on which a scheduling order is due under Rule 16(b) of the Federal Rules of Civil Procedure, a statement that such party holds a good faith belief, based on publicly available information and any other information known to such party, that the party alleging infringement has no substantial interest in the subject matter at issue other than asserting the patent in litigation.
“(B) Certification—This subsection shall not apply to an action if the party alleging infringement files, not later than 45 days after the date on which such party is served with the initial statement described under subparagraph (A), a certification that—
“(i) establishes and certifies to the court, under oath, that such party will have sufficient funds available to satisfy any award of reasonable attorney’s fees and expenses under section 285 if an award is assessed;
“(ii) demonstrates that such party has a substantial interest in the subject matter at issue other than asserting the patent in litigation; or
“(iii) is made under oath that there are no other interested parties.
“(5) Exception for university technology transfer organizations—This subsection shall not apply to a technology transfer organization whose primary purpose is to facilitate the commercialization of technologies developed by one or more institutions of higher education (as defined in section 101(a) of the Higher Education Act of 1965 (20 U.S.C. 1001(a))) if such technology transfer organization is alleging infringement on behalf of an entity that would not be subject to this subsection.
“(6) Interested party defined—In this subsection, the term interested party means a person, other than the party alleging infringement, that—
“(A) is an assignee of the patent or patents at issue;
“(B) has a right, including a contingent right, to enforce or sublicense the patent or patents at issue; or
“(C) has a direct financial interest in the patent or patents at issue, including the right to any part of an award of damages or any part of licensing revenue, except that a person with a direct financial interest does not include—
“(i) an employee of the party alleging infringement—
“(I) whose principal source of income or employment is employment with the party alleging infringement; or
“(II) whose sole financial interest in the patent or patents at issue is a salary or hourly wage paid by the party alleging infringement;
“(ii) an attorney or law firm providing legal representation in the civil action described in paragraph (1) if the sole basis for the financial interest of the attorney or law firm in the patent or patents at issue arises from the attorney or law firm’s receipt of compensation reasonably related to the provision of the legal representation; or
“(iii) a person whose sole financial interest in the patent or patents at issue is ownership of an equity or security interest in the party alleging infringement, unless such person also has the right or ability to direct or control (membership on the board of directors alone is not sufficient to demonstrate such right or ability) the civil action.
“(7) Substantial interest—In this subsection, the term substantial interest includes an interest in the subject matter of a patent at issue if the party—
“(A) invented the subject matter; or
“(B) commercially practices or implements, made substantial preparations directed particularly to commercially practicing or implementing, or is engaged in research and development in, technology in the field of the subject matter.”
“281B. Stay of discovery pending a preliminary motion.
“(a) In general—Except as provided in subsection (d), in an action for patent infringement under section 271 or an action for a declaratory judgement that a patent is invalid or not infringed, discovery shall be stayed if—
“(1) the defendant moves to—
“(A) sever a claim or drop a party for misjoinder under Rule 21 of the Federal Rules of Civil Procedure;
“(B) transfer the action under section 1404(a) of title 28;
“(C) transfer or dismiss the action under section 1406(a) of title 28; or
“(D) dismiss the action pursuant to Federal Rule of Civil Procedure 12(b); and
“(2) such motion is filed within 90 days after service of the complaint and includes a declaration or other evidence in support of the motion.
“(b) Expiration of stay—A stay entered under subsection (a) shall expire when all motions that are the basis for the stay are decided by the court.
“(c) Priority of decision—In an action described in subsection (a), the court shall decide a motion to sever a claim or drop a party for misjoinder under Rule 21 of the Federal Rules of Civil Procedure, to transfer under section 1404(a) to title 28, to transfer or dismiss under 1406(a) of title 28, or to dismiss the action pursuant to Federal Rule of Civil Procedure 12(b) before the earlier of the date on which the court—
“(1) decides any other substantive motion, provided however that the court may decide a question of its own jurisdiction at any time; or
“(2) issues a scheduling order under Rule 16(b) of the Federal Rules of Civil Procedure.
“(d) Exception
“(1) Discovery necessary to decide motion—Notwithstanding subsection (a), the court may allow such discovery as the court determines to be necessary to decide a motion to sever, drop a party, dismiss, or transfer.
“(2) Competitive harm—Subsections (a) and (c) shall not apply to an action in which the patentee is granted a preliminary injunction to prevent harm arising from the manufacture, use, sale, offer for sale, or importation of an allegedly infringing product or process that competes with a product or process made, sold, or offered for sale by the patentee.
“(3) Consent of the parties—The patentee and an opposing party shall be excluded, in whole or in part, from the limitations of subsections (a) and (c) upon such parties’ filing with the court a signed stipulation agreeing to such exclusion.
“(4) FDA and biological product application—Subsections (a) and (c) shall not apply to an action that includes a cause of action described under section 271(e)(2).”
“(c) Willful infringement—A claimant seeking to establish willful infringement may not rely on evidence of pre-suit notification of infringement unless that notification identifies with particularity the asserted patent, identifies the product or process accused, identifies the ultimate parent entity of the claimant, and explains with particularity, to the extent possible following a reasonable investigation or inquiry, how the product or process infringes one or more claims of the patent.”
“(b) Venue for action relating to patents—Notwithstanding subsections (b) and (c) of section 1391 of this title, any civil action for patent infringement or any action for a declaratory judgment that a patent is invalid or not infringed may be brought only in a judicial district—
“(1) where the defendant has its principal place of business or is incorporated;
“(2) where the defendant has committed an act of infringement of a patent in suit and has a regular and established physical facility that gives rise to the act of infringement;
“(3) where the defendant has agreed or consented to be sued in the instant action;
“(4) where an inventor named on the patent in suit conducted research or development that led to the application for the patent in suit;
“(5) where a party has a regular and established physical facility that such party controls and operates, not primarily for the purpose of creating venue, and has—
“(A) engaged in management of significant research and development of an invention claimed in a patent in suit prior to the effective filing date of the patent;
“(B) manufactured a tangible product that is alleged to embody an invention claimed in a patent in suit; or
“(C) implemented a manufacturing process for a tangible good in which the process is alleged to embody an invention claimed in a patent in suit; or
“(6) for foreign defendants that do not meet the requirements of paragraphs (1) or (2), according to section 1391(d) of this title.”
Sec. 4 Transparency of patent ownership
“(b) Initial disclosure
“(1) In general—Except as provided in paragraph (2), upon the filing of an initial complaint for patent infringement, the plaintiff shall disclose to the Patent and Trademark Office, the court, and each adverse party the identity of each of the following:
“(A) The assignee of the patent or patents at issue.
“(B) Any entity with a right to sublicense or enforce the patent or patents at issue.
“(C) Any entity, other than the plaintiff, that the plaintiff knows to have a financial interest in the patent or patents at issue or the plaintiff.
“(D) The ultimate parent entity of any assignee identified under subparagraph (A) and any entity identified under subparagraph (B) or (C).
“(E) A clear and concise description of the principal business, if any, of the party alleging infringement.
“(F) A list of each complaint filed, of which the party alleging infringement has knowledge, that asserts or asserted any of the patents identified under subparagraph (A).
“(G) For each patent identified under subparagraph (A), whether a standard-setting body has specifically declared such patent to be essential, potentially essential, or having potential to become essential to that standard-setting body, and whether the United States Government or a foreign government has imposed specific licensing requirements with respect to such patent.
“(2) Exemption—The requirements of paragraph (1) shall not apply with respect to a civil action filed under subsection (a) that includes a cause of action described under section 271(e)(2).
“(c) Disclosure compliance
“(1) Publicly traded—For purposes of subsection (b)(1)(C), if the financial interest is held by a corporation traded on a public stock exchange, an identification of the name of the corporation and the public exchange listing shall satisfy the disclosure requirement.
“(2) Not publicly traded—For purposes of subsection (b)(1)(C), if the financial interest is not held by a publicly traded corporation, the disclosure shall satisfy the disclosure requirement if the information identifies—
“(A) in the case of a partnership, the name of the partnership and the name and correspondence address of each partner or other entity that holds more than a 5-percent share of that partnership;
“(B) in the case of a corporation, the name of the corporation, the location of incorporation, the address of the principal place of business, and the name of each officer of the corporation; and
“(C) for each individual, the name and correspondence address of that individual.
“(d) Ongoing duty of disclosure to the Patent and Trademark Office
“(1) In general—A plaintiff required to submit information under subsection (b) or a subsequent owner of the patent or patents at issue shall, not later than 90 days after any change in the assignee of the patent or patents at issue or an entity described under subparagraph (B) or (D) of subsection (b)(1), submit to the Patent and Trademark Office the updated identification of such assignee or entity.
“(2) Failure To Comply—With respect to a patent for which the requirement of paragraph (1) has not been met—
“(A) the plaintiff or subsequent owner shall not be entitled to recover reasonable fees and other expenses under section 285 or increased damages under section 284 with respect to infringing activities taking place during any period of noncompliance with paragraph (1), unless the denial of such damages or fees would be manifestly unjust; and
“(B) the court shall award to a prevailing party accused of infringement reasonable fees and other expenses under section 285 that are incurred to discover the updated assignee or entity described under paragraph (1), unless such sanctions would be unjust.
“(e) Definitions—In this section:
“(1) Financial interest—The term financial interest—
“(A) means—
“(i) with regard to a patent or patents, the right of a person to receive proceeds related to the assertion of the patent or patents, including a fixed or variable portion of such proceeds; and
“(ii) with regard to the plaintiff, direct or indirect ownership or control by a person of more than 5 percent of such plaintiff; and
“(B) does not mean—
“(i) ownership of shares or other interests in a mutual or common investment fund, unless the owner of such interest participates in the management of such fund; or
“(ii) the proprietary interest of a policyholder in a mutual insurance company or of a depositor in a mutual savings association, or a similar proprietary interest, unless the outcome of the proceeding could substantially affect the value of such interest.
“(2) Proceeding—The term proceeding means all stages of a civil action, including pretrial and trial proceedings and appellate review.
“(3) Ultimate parent entity
“(A) In general—Except as provided in subparagraph (B), the term ultimate parent entity has the meaning given such term in section 801.1(a)(3) of title 16, Code of Federal Regulations, or any successor regulation.
“(B) Modification of definition—The Director may modify the definition of ultimate parent entity by regulation.”
Sec. 5 Customer-suit exception
“296. Stay of action against customer
“(a) Definitions—In this section:
“(1) Covered customer—The term covered customer means a retailer or end user that is accused of infringing a patent or patents in dispute based on—
“(A) the sale, or offer for sale, of a covered product or covered process without material modification of the product or process in a manner that is alleged to infringe a patent or patents in dispute; or
“(B) the use by such retailer, the retailer’s end user customer, or an end user of a covered product or covered process without material modification of the product or process in a manner that is alleged to infringe a patent or patents in dispute.
“(2) Covered manufacturer—The term covered manufacturer means a person that manufactures or supplies, or causes the manufacture or supply of, a covered product or covered process, or a relevant part thereof.
“(3) Covered process—The term covered process means a process, method, or a relevant part thereof, that is alleged to infringe a patent or patents in dispute where such process, method, or relevant part thereof is implemented by an apparatus, material, system, software, or other instrumentality that is provided by the covered manufacturer.
“(4) Covered product—The term covered product means a product, system, service, component, material, or apparatus, or relevant part thereof, that—
“(A) is alleged to infringe a patent or patents in dispute; or
“(B) implements a process alleged to infringe the patent or patents in dispute.
“(5) End user—The term end user includes an affiliate of an end user, but does not include an entity that manufacturers or causes the manufacture of a covered product or covered process, or a relevant part thereof.
“(6) Retailer—The term retailer means an entity that generates revenues predominately through the sale to the public of consumer goods or services, or an affiliate of such entity, but does not include an entity that manufacturers or causes the manufacturer of a covered product or covered process, or a relevant part thereof.
“(b) Stay of action against customer—Except as provided in subsection (d), in any civil action in which a party asserts a claim for relief arising under any Act of Congress relating to patents, the court shall grant a motion to stay at least the portion of the action against a covered customer related to infringement of a patent involving a covered product or covered process if the following requirements are met:
“(1) Party to the action—The covered manufacturer is a party to the action or to a separate action (in which a party asserts a claim for relief arising under any Act of Congress relating to patents) involving the same patent or patents related to the same covered product or covered process.
“(2) Agreement to be bound by issues determined—The covered customer agrees to be bound as to issues determined in an action described in paragraph (1) without a full and fair opportunity to separately litigate any such issue, but only as to those issues for which all other elements of the common law doctrine of issue preclusion are met.
“(3) Deadline to file motion—The motion is filed after the first pleading in the action but not later than the later of—
“(A) the 120th day after the date on which the first pleading or paper in the action is served that specifically identifies the covered product or covered process as a basis for the covered customer’s alleged infringement of the patent and that specifically identifies how the covered product or covered process is alleged to infringe the patent; or
“(B) the date on which the first scheduling order in the case is entered.
“(4) Manufacturer consent in certain cases—In a case in which the covered manufacturer has been made a party to the action on motion by the covered customer, the covered manufacturer and the covered customer consent in writing to the stay.
“(c) Lift of stay
“(1) In general—A stay entered under this section may be lifted upon grant of a motion based on a showing that—
“(A) the action involving the covered manufacturer will not resolve a major issue in the suit against the covered customer (such as a covered product or covered process identified in the motion to lift the stay is not a material part of the claimed invention or inventions in the patent or patents in dispute); or
“(B) the stay unreasonably prejudices or would be manifestly unjust to the party seeking to lift the stay.
“(2) Separate manufacturer action involved—In the case of a stay entered under this section based on the participation of the covered manufacturer in a separate action described in subsection (b)(1), a motion under paragraph (1) may only be granted if the court in such separate action determines that the showing required under paragraph (1) has been made.
“(d) Exemption—This section shall not apply to an action that includes a cause of action described under section 271(e)(2).
“(e) Waiver of estoppel effect—The court may, upon motion, determine that a consent judgment or an unappealed final order shall not be binding on the covered customer with respect to one or more of the issues that gave rise to the stay based on a showing that such consent judgment or unappealed final order would unreasonably prejudice or be manifestly unjust to the covered customer in light of the circumstances of the case if, following the grant of a motion to stay under this section, the covered manufacturer described in subsection (b)(1)—
“(1) obtains or consents to entry of a consent judgment relating to such issue that gave rise to the stay; or
“(2) fails to prosecute to a final, non-appealable judgment such issue that gave rise to the stay.
“(f) Rule of construction—Nothing in this section shall be construed to limit the ability of a court to grant any stay, expand any stay granted under this section, or grant any motion to intervene, if otherwise permitted by law.”
Sec. 6 Procedures and practices to implement recommendations of the Judicial Conference
“(e) Section 365(n) shall apply to cases under this chapter. If the foreign representative rejects or repudiates a contract under which the debtor is a licensor of intellectual property, the licensee under such contract shall be entitled to make the election and exercise the rights described in section 365(n).”
“(G) a trademark, service mark, or trade name, as those terms are defined in section 45 of the Act of July 5, 1946 (commonly referred to as the “Trademark Act of 1946”) (15 U.S.C. 1127);”
“(D) in the case of a trademark, service mark, or trade name, the licensee shall not be relieved of any of its obligations to maintain the quality of the products and services offered under or in connection with the licensed trademark, service mark, or trade name, and the trustee shall retain the right to oversee and enforce quality control for such products or services, or both.”
Sec. 7 Small business education, outreach, and information access
Sec. 8 Studies on patent transactions, quality, and examination
Sec. 9 Improvements and technical corrections to the Leahy-Smith America Invents Act
“(14) providing that for all purposes under this chapter—
“(A) each claim of a patent shall be construed as such claim would be in a civil action to invalidate a patent under section 282(b), including construing each claim of the patent in accordance with the ordinary and customary meaning of such claim as understood by one of ordinary skill in the art and the prosecution history pertaining to the patent; and
“(B) if a court has previously construed the claim or a claim term in a civil action in which the patent owner was a party, the Office shall consider such claim construction; and
“(15) providing that a review may not be instituted unless the petitioner certifies that the petitioner and the real parties in interest of the petitioner—
“(A) do not own and will not acquire a financial instrument (including a prepaid variable forward contract, equity swap, collar, or exchange fund) that is designed to hedge or offset any decrease in the market value of an equity security of the patent owner or an affiliate of the patent owner, during a period following the filing of the petition to be determined by the Director; and
“(B) have not demanded payment, monetary or otherwise, from the patent owner or an affiliate of the patent owner in exchange for a commitment not to file a petition under section 311 with respect to the patent that is the subject of the petition, unless the petitioner or the real party in interest of the petitioner has been sued for or charged with infringement of the patent, during a period to be determined by the Director.”
“(13) providing that for all purposes under this chapter—
“(A) each claim of a patent shall be construed as such claim would be in a civil action to invalidate a patent under section 282(b), including construing each claim of the patent in accordance with the ordinary and customary meaning of such claim as understood by one of ordinary skill in the art and the prosecution history pertaining to the patent; and
“(B) if a court has previously construed the claim or a claim term in a civil action in which the patent owner was a party, the Office shall consider such claim construction; and
“(14) providing that a review may not be instituted unless the petitioner certifies that the petitioner and the real parties in interest of the petitioner—
“(A) do not own and will not acquire a financial instrument (including a prepaid variable forward contract, equity swap, collar, or exchange fund) that is designed to hedge or offset any decrease in the market value of an equity security of the patent owner or an affiliate of the patent owner, during a period following the filing of the petition to be determined by the Director; and
“(B) have not demanded payment, monetary or otherwise, from the patent owner or an affiliate of the patent owner in exchange for a commitment not to file a petition under section 311 with respect to the patent that is the subject of the petition, unless the petitioner or the real party in interest of the petitioner has been sued for or charged with infringement of the patent, during a period to be determined by the Director.”
“(2) if—
“(A) no such preliminary response is filed, the last date on which such response may be filed; and
“(B) such preliminary response is filed and no such reply is requested, the last day on which such reply may be requested.”
“(e) Double-patenting prior art—If a first claimed invention in a first patent was effectively filed on or before the effective filing date of a second claimed invention in a second patent or in the application on which the second patent issues, and the first claimed invention is not otherwise prior art to the second claimed invention under this section, then the first claimed invention shall, notwithstanding the other subsections of this section, constitute prior art to the second claimed invention under this subsection unless—
“(1) the second claimed invention is consonant with a requirement for restriction under the first sentence of section 121 with respect to the claims issued in the first patent; or
“(2) an election has been recorded in the Office by the owner of the second patent or the application on which the second patent issues disclaiming the right to bring or maintain a civil action under section 281 to enforce the second patent, except that such disclaimer shall not apply if—
“(A) the relief being sought in the civil action would not constitute a cause of action barred by res judicata had the asserted claims of the second patent been issued in the first patent; and
“(B) the owner of the first patent or the application on which the first patent issues has recorded an election limiting the enforcement of the first patent relative to the second patent in the manner described in this paragraph, the owner of the first patent is a party to the civil action, or a separate action under section 281 to enforce the first patent can no longer be brought or maintained.”
“(D) Patents subject to election—If a patent is subject to an election as described in section 102(e)(2) with respect to one or more other patents, the adjusted term of the patent under this subsection may not exceed a period of 17 years from the date of issuance of any of such other patents and the portion of any adjustment of the term of the patent under this subsection that extends beyond the expiration of such 17-year period years shall be void.”
“(c) Joinder
“(1) Joinder of party—If the Director institutes an inter partes review, the Director, in his or her discretion, may join as a party to that inter partes review any person who meets the requirement of properly filing a petition under section 311 that the Director, after receiving a preliminary response under section 313 or the expiration of the time for filing such a response, determines warrants the institution of an inter partes review under section 314.
“(2) Joinder of later filed petition—For good cause shown, the Director may allow a party who files a petition that meets the requirement described in paragraph (1) and concerns the patent of a pending inter partes review to join the petition to the pending review.”
“(c) Duration—The program established under subsection (a) shall be maintained using existing resources, and shall terminate 20 years after the end of the 6-month period described in subsection (b).”
“(f) Foreign or International Filing
“(1) Provision of information—The Director may provide information concerning an application for patent to a foreign or international intellectual property office if a corresponding application is filed with such foreign or international intellectual property office. If the corresponding application is an international application, such information may also be provided to an International Searching Authority, an International Preliminary Examining Authority, or the International Bureau.
“(2) Definitions—For purposes of this subsection, the terms international application, International Searching Authority, International Preliminary Examining Authority, and International Bureau have the same meaning given those terms under section 351.”